Evaluation of the clinical effect of antineoplastic drugs
Nissen, N.I.
Ugeskrift for Laeger 134(25): 1345-1346
1972
ISSN/ISBN: 0041-5782 PMID: 5048880 Document Number: 50729
Document emailed within 1 workday
Related Documents
Greco, F.A.; Hande, K.R. 1979: The clinical pharmacology and use of antineoplastic drugs Journal of the Tennessee Medical Association 72(1): 23-33Hall, T.C. 1978: Steroid carriers of cytotoxic agents: evaluation of antineoplastic effects of drugs and animal models Cancer Treatment Reports 62(8): 1263-1264
Feifel, G.; Thurmayr, R. 1970: Clinical evaluation of the analgesic effect of drugs in postoperative pains. (Comparative clinical trial of piritramide) Der Anaesthesist 19(10): 369-373
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
Pashinskiĭ, V.G. 1971: The effect of water-salt regimen on the growth of transplantable tumors and the activity of antineoplastic drugs Voprosy Onkologii 17(3): 77-80
Iavorskaia, N.P. 1971: Probit-analysis in the evaluation of the selectivity of antineoplastic effect of agents Voprosy Onkologii 17(8): 90-94
Trissel, L.A.; Parks, N.P.; Santiago, N.M. 1991: Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection American Journal of Hospital Pharmacy 48(10): 2186-2189
Hamada, K.; Sakamoto, M.; Mikasa, K.; Teramoto, M.; Mori, K.; Tsujimoto, M.; Maeda, K.; Konishi, M.; Sawaki, M.; Narita, N.; Kita, E. 1997: Evaluation of antineoplastic effect of CAM (clarithromycin) in a mouse model inoculated with lung cancer cells Japanese Journal of Antibiotics 50 Suppl A: 28-31
Ráz, K.; Francová, V.; Franc, Z.; Cerný, A.; Jelínek, V.; Semonský, M. 1970: Biochemistry of drugs. XVI. Substances with antineoplastic effect. XXXVI. Absorption, tissue distribution and excretion of ethylester N--delta-(6--purinylthio) varleryl-glycylglycine-35S (Butodicine) in mice with Crocker's sarcoma 180 Neoplasma 17(1): 37-42
Ng, L.M.; Jaffe, N. 1970: Possible hazards of handling antineoplastic drugs Pediatrics 46(4): 648-649
Neiger, R. 1996: Guidelines for the handling of antineoplastic drugs Schweizer Archiv für Tierheilkunde 138(8): 383-386
Williams, S.F.; Schilsky, R.L. 2000: Antineoplastic drugs administered during pregnancy Seminars in Oncology 27(6): 618-622
Williams, S.F.; Schilsky, R.L. 2000: Antineoplastic drugs administered during pregnancy Seminars in Oncology 27(6): 618-622
Szmigiero, L. 1988: Topoisomerase Ii as a cellular receptor of various antineoplastic drugs Postepy Biochemii 34(3): 147-152
Kuduk-Jaworska, J. 1984: Platinum complexes as potential antineoplastic drugs Postepy Higieny i Medycyny Doswiadczalnej 38(3): 281-322
Buja, L.M.; Ferrans, V.J. 1975: Myocardial injury produced by antineoplastic drugs Recent Advances in Studies on Cardiac Structure and Metabolism 6: 487-497
Gallelli, J.F.; Mahar, H. 1986: Chemical destruction and disposal of antineoplastic drugs American Journal of Hospital Pharmacy 43(7): 1679
Pavone-Macaluso, M.; Rizzo, F.P.; Caramia, G.; Ascoli, R.; Gebbia, N.; Biondo, F.; Mazzarese, S.; Butera, G. 1975: Absorption of drugs through the bladder. Experiences with antineoplastic agents Recenti Progressi in Medicina 59(5): 479-496
Luisetti, M.; Peona, V.; Salmona, M.; Pagnoni, A.M.; Villani, F.; Knerich, R.; Genghini, M.; Abbà, L.; Pozzi, E. 1986: Ambroxol and pulmonary toxicity induced by antineoplastic drugs International Journal of Clinical Pharmacology Research 6(2): 129-136
Zhao, Z.Z.; Huang, M.T. 1992: A study of vitamin inhibition on the mutagenicity of the antineoplastic drugs Zhonghua Yu Fang Yi Xue Za Zhi 26(5): 291-293